Despite Merck KGaA’s lupus drug failing to prove itself against one form of the autoimmune disease, the German drugmaker has ...

By Ludwig Burger FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more ...

Today, Benzinga 's options scanner spotted 33 uncommon options trades for Merck & Co. This isn't normal. The overall ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge ...

The global, randomized IDeate-Esophageal01 study will evaluate ifinatamab deruxtecan, a B7-H3–targeted antibody-drug conjugate, versus physician’s choice of chemotherapy in patients with advanced or ...

Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

(Reuters) -Merck Animal Health, a unit of Merck, said on Thursday it would invest $895 million to expand its manufacturing ...